The present study showed that ADAM17 expression had a positive correlation with EGFR expression indicating that in patients with esophageal squamous cell carcinoma, certain target EGFR drugs produce tolerance. The gene discussed is ADAM17; the disease is esophageal squamous cell carcinoma.